Agilent Technologies, Inc.

A · Healthcare · · USD

133.95 USD

+0.00 (0.27%)

● Updated 2026-07-10 17:08 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

/ 100

Technical 50

Trend & RS 79

Momentum 56

Fundamental 78

Macro 71

Liquidity 36

Component	Score	Weight
Technical	50.0	20%
Trend & RS	78.7	30%
Momentum	56.1	15%
Fundamental	77.8	10%
Macro	71.2	20%
Liquidity	35.8	5%

Trade Setup

Entry	133.96
Stop Loss	125.84 (6.1%)
Target 1 (1:1)	142.08 (+6.1%)
Target 2 (2:1)	150.20 (+12.1%)

ATR(14)	4.06 (3.0%)
Risk per Share	8.12
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	50.4	+0.01
Momentum	56.1	+0.24
Quality	55.8	+0.23
Composite	54.1

Quality Scores

Piotroski F-Score 7 /9 — Strong

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Overvalued

Metric	Stock	Sector	vs Peers
P/E Ratio	26.9	22.0	+22% above
P/B Ratio	5.3	4.0	Above
Dividend Yield	76.0%	1.5%	Above avg

Comparing against Healthcare median multiples.

Trading at a premium to sector peers — verify growth justifies premium.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

86.23

Market Price

133.95

Upside

-35.6%

Margin of Safety	-55.3%
Stage 1 PV (5yr FCF)	5,782,796,629
Terminal Value PV	18,572,680,069
Total Enterprise Value	24,355,476,698

Assumptions

Base FCF	1,125,208,833
Growth Rate (5yr)	10.0%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

43.16%

Full Kelly

21.58%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 66/100. Estimated win rate 60%, avg win 8.9%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary BUY

Bullish Signals

Bearish Signals

58.2

RSI(14)

1.7545

MACD

Relative Strength (RS) IMPROVING

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	↑ RISING (+5.3% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (9d since high)
Sector Outperformance	+13.0% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

Indicator	Value	Signal
Rsi	58.2	NEUTRAL
Macd	1.7545	BEARISH
Ma Cross	124.79 / 130.27	DEATH CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.06x	LOW

Key Levels

Level	Price
52-Week High	160.27
Bollinger Upper	136.89
SMA(200)	130.27
SMA(50)	124.79
SMA(20)	130.56
Current Price	133.95
Bollinger Lower	124.23
52-Week Low	108.35
ATR(14)	4.06

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence

100%

Acc: 0.0 | Dist: 0.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-06	Normal	0.89x	Normal bar — no special VSA pattern
2026-07-07	Normal	1.1x	Normal bar — no special VSA pattern
2026-07-08	Normal	0.96x	Normal bar — no special VSA pattern
2026-07-09	Normal	1.06x	Normal bar — no special VSA pattern
2026-07-10	Normal	0.06x	Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	132.29	Above Kijun
Kijun-sen (26)	132.14	Base line
Senkou A	132.21	Leading span A
Senkou B	124.48	Leading span B
Cloud	124.48 – 132.21	Bullish (Green)
Price vs Cloud	133.96	Above Cloud
Chikou Span	137.14	Bearish
Alignment Score	3/4	BULLISH